Citigroup’s Advantest Corp ATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-15
Closed 8086
2015
Q4
$0 Sell
15
-662
-98% -$5.57K ﹤0.01% 8166
2015
Q3
$5K Sell
677
-767
-53% -$6.63K ﹤0.01% 6786
2015
Q2
$15K Buy
1,444
+360
+33% +$4.21K ﹤0.01% 6274
2015
Q1
$13K Buy
1,084
+5
+0.5% +$63 ﹤0.01% 6358
2014
Q4
$13K Buy
1,079
+60
+6% +$722 ﹤0.01% 6403
2014
Q3
$13K Buy
1,019
+203
+25% +$2.42K ﹤0.01% 6154
2014
Q2
$10K Buy
816
+346
+74% +$3.94K ﹤0.01% 6193
2014
Q1
$5K Sell
470
-122
-21% -$1.33K ﹤0.01% 6615
2013
Q4
$6K Sell
592
-169
-22% -$2.06K ﹤0.01% 6588
2013
Q3
$8K Buy
761
+17
+2% +$232 ﹤0.01% 6307
2013
Q2
$13K Buy
+744
New +$11.5K ﹤0.01% 6011

Other funds holding ATE

Citigroup's ATE Position: Q1 2016 in Review

Citigroup sold out of Advantest Corp (ATE) in Q1 2016, closing a stake of 15 shares.

Citigroup first reported a position in ATE in Q2 2013 and held it in 11 quarters. The position peaked at $15K in Q2 2015. 14 funds tracked by Wall St. Rank hold ATE as of Q1 2016.

  • Citigroup reported no remaining Advantest Corp position as of Q1 2016 after selling out during the quarter.
  • Citigroup sold 15 Advantest Corp shares in Q1 2016.
  • Citigroup first reported a position in Advantest Corp in Q2 2013 and held it in 11 quarters.
  • Citigroup's Advantest Corp position peaked at $15K in Q2 2015.
  • 14 funds tracked by Wall St. Rank held Advantest Corp as of Q1 2016.

Based on Citigroup's 13F filing for Q1 2016, filed 13 May 2016.